We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+9.44%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$5.39B
AUM Growth
+$133M
Cap. Flow
-$208M
Cap. Flow %
-3.86%
Top 10 Hldgs %
12.8%
Holding
367
New
31
Increased
69
Reduced
178
Closed
28

Top Buys

Rank Stock Value
1
U icon
Unity
U
+$46.5M
2
DOCU
DocuSign
DOCU
+$45.3M
3
HRB icon
H&R Block
HRB
+$19M
4
ELF icon
e.l.f. Beauty
ELF
+$18.3M
5
WMS icon
Advanced Drainage Systems
WMS
+$17.8M

Sector Composition

Rank Sector Weight
1 Technology 20.49%
2 Healthcare 17.06%
3 Financials 15.2%
4 Consumer Discretionary 13.23%
5 Industrials 12.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXSM icon
251
Axsome Therapeutics
AXSM
$11.4B
$7.27M 0.13%
128,405
-17,920
-12% -$1.26M
FOLD
252
DELISTED
Amicus Therapeutics
FOLD
$6.82M 0.13%
689,787
+18,969
+3% +$294K
CNST
253
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$6.49M 0.12%
+277,419
New +$8.4M
ACHL
254
DELISTED
Achilles Therapeutics
ACHL
$5.33M 0.1%
+322,261
New +$5.33M
IMVT icon
255
Immunovant
IMVT
$8.69B
$4.92M 0.09%
307,003
+142,386
+86% +$3.75M
BDTX icon
256
Black Diamond Therapeutics
BDTX
$118M
$4.47M 0.08%
184,253
-25,658
-12% -$692K
UVE icon
257
Universal Insurance Holdings
UVE
$1.18B
$3.04M 0.06%
211,897
-273,672
-56% -$4.09M
DAR icon
258
Darling Ingredients
DAR
$9.91B
$2.08M 0.04%
28,221
-3,100
-10% -$213K
ZBRA icon
259
Zebra Technologies
ZBRA
$17.8B
$1.96M 0.04%
4,034
-146
-3% -$65.1K
MANH icon
260
Manhattan Associates
MANH
$11.2B
$1.82M 0.03%
15,497
-507
-3% -$61.4K
SI
261
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$1.78M 0.03%
21,631
ADSK icon
262
Autodesk
ADSK
$52.1B
$1.76M 0.03%
6,355
-228
-3% -$65.8K
CGNX icon
263
Cognex
CGNX
$10.4B
$1.76M 0.03%
21,162
KSU
264
DELISTED
Kansas City Southern
KSU
$1.72M 0.03%
6,516
PNFP icon
265
Pinnacle Financial Partners Inc
PNFP
$16B
$1.68M 0.03%
18,901
-212,984
-92% -$16.9M
ANSS
266
DELISTED
Ansys
ANSS
$1.56M 0.03%
4,597
TSCO icon
267
Tractor Supply
TSCO
$18.5B
$1.56M 0.03%
43,955
MTZ icon
268
MasTec
MTZ
$22.7B
$1.51M 0.03%
16,070
-465,933
-97% -$39.9M
BG icon
269
Bunge Global
BG
$21.4B
$1.46M 0.03%
18,400
+18,220
+10,122% +$1.35M
CTLT
270
DELISTED
CATALENT, INC.
CTLT
$1.43M 0.03%
13,584
DHR icon
271
Danaher
DHR
$144B
$1.36M 0.03%
6,838
THO icon
272
Thor Industries
THO
$4.08B
$1.36M 0.03%
10,071
TECH icon
273
Bio-Techne
TECH
$11.3B
$1.34M 0.02%
14,076
NOVT icon
274
Novanta
NOVT
$6.26B
$1.34M 0.02%
10,181
ROK icon
275
Rockwell Automation
ROK
$49.8B
$1.33M 0.02%
5,024

Similar funds

Peregrine Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Peregrine Capital Management held 367 positions worth $5.39B, up 2.5% from $5.26B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Peregrine Capital Management withdrew a net $208M in Q1 2021, closing 28 positions and reducing 178 holdings. Its most notable exit was ENVESTNET, INC., an estimated $41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Peregrine Capital Management opened a new position in Unity worth $37.9M.

  • Peregrine Capital Management's largest Q1 2021 buy was Unity: 377,615 shares worth $37.9M.
  • Peregrine Capital Management added most to DexCom in Q1 2021, an estimated $13.8M increase.
  • Peregrine Capital Management's biggest Q1 2021 reduction was MasTec, cutting an estimated $39.9M.
  • Peregrine Capital Management fully exited ENVESTNET, INC. in Q1 2021, selling an estimated $41M.
  • Peregrine Capital Management's ten largest holdings make up 13% of its $5.39B portfolio in Q1 2021.
  • Peregrine Capital Management opened 31 new positions and closed 28 in Q1 2021.
  • Peregrine Capital Management's portfolio value rose 2.5% quarter-over-quarter to $5.39B.

Based on Peregrine Capital Management's 13F filing for Q1 2021, filed 11 May 2021.